Venture-Backed Startups

EMCO Chemical Distributors supplies over 4,000 industrial and specialty chemicals to customers across multiple industries. The company operates as a one-stop distributor for chemical procurement needs.

1 investor

Emdash is a free, open-source agentic development environment that runs coding agents like Claude Code and Codex in parallel across isolated Git worktrees, schedules recurring agent runs, and lets developers review diffs, PRs, and CI in one place. It targets software developers and is available for macOS, Windows, and Linux, with support for remote SSH and bring-your-own infrastructure.

1 investor

Emdash is an open-source development environment for running coding agents in parallel with task scheduling and diff review capabilities. It supports multiple agent types and works across macOS, Windows, and Linux.

1 investor

EMED makes infusion pump systems and subcutaneous delivery devices for patients requiring immunoglobulin therapy and other biologics. The company's portfolio includes mechanical and electronic infusion pumps, needle sets, and accessories designed for both home and clinical use.

1 investor

Emedgene provides genomic interpretation software that uses explainable AI and automation to prioritize, interpret, curate, and classify genetic variants from sequencing (WGS, WES, panels) and microarray data. It serves clinical and research genetics laboratories conducting rare disease research, hereditary risk assessment, carrier screening, and similar genetic disease testing workflows, and integrates with Illumina's DRAGEN secondary analysis.

2 investors

eMedicalSentry provides remote patient monitoring (RPM) and telehealth services that let hospitals and healthcare providers track and communicate with patients remotely to reduce 30-day readmissions and avoid Medicare penalties. Its care coordination platform works with existing and future devices and includes reporting on individual and population-wide outcomes such as HEDIS/Stars and Homecare Compare quality ratings.

2 investors

eMenu International develops interactive digital menu technology for restaurants and hospitality venues using iPad-based systems. The company serves restaurants, hotels, and hospitality establishments across the United States and internationally, helping them enhance guest experiences and sales.

1 investor

Emerald is a venture capital and investor services firm based in Zurich that supports corporate and institutional investors in identifying and advancing innovation-focused business opportunities, particularly in the power, mobility, and energy sectors.

1 investor

Emerald offers comprehensive health testing (124 biomarkers), clinician-reviewed results, wearable and historical data integration, and ongoing care to help individuals identify metabolic, cardiovascular, and weight-related risks earlier. The service also includes weight management support and in-app GP chat access for proactive, preventive healthcare.

2 investors

Emerald Inno develops a contactless health monitoring device that uses radio wave analysis and machine learning to detect human movement and extract clinical health data without wearables or manual data synchronization. The platform serves clinical research and health studies with proprietary algorithms that process behavioral and movement data.

1 investor

Emerald AI develops software to enable power flexibility in data centers by orchestrating power demand in response to grid needs. The company applies AI and machine learning to optimize cloud computing systems for grid-aware operations.

7 investors

Emerald BioAgriculture develops biology-based products and solutions using advanced biomanufacturing processes for plant, animal, and human health across various markets. The company specializes in biochemistry, microbials, enzymes, amino acids, peptides, and nutrients with integrated capabilities from discovery through manufacturing.

1 investor

0 investors

0 investors

Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab. It serves pharmaceutical, biotech, consumer products, academic, and contract research organizations across applications such as discovery, CMC, DMPK, and diagnostics.

4 investors

0 investors

0 investors

Emerald Horizon develops next-generation small modular reactors (ADES) using thorium and particle acceleration technology, paired with integrated energy storage systems, for carbon-free baseload power generation. The company operates through an Energy-as-a-Service model targeting industrial customers, data centers, and critical infrastructure in Europe.

1 investor

0 investors

0 investors

0 investors

0 investors

0 investors

0 investors